1Hirasawa, A, Hara, T, Katsuma, S, et al. (2008) Free fatty acid receptors and drug discovery. Biol Pharm Bull 31, 1847–1851.
2Swaminath, G (2008) Fatty acid binding receptors and their physiological role in type 2 diabetes. Arch Pharm 341, 753–761.
3Wellendorph, P, Johansen, LD & Brauner-Osborne, H (2009) Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol Pharmacol 76, 453–465.
4Brown, AJ, Goldsworthy, SM, Barnes, AA, et al. (2003) The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278, 11312–11319.
5Le Poul, E, Loison, C, Struyf, S, et al. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278, 25481–25489.
6Liaw, CW & Connolly, DT (2009) Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. DNA Cell Biol 28, 555–560.
7Cummings, JH, Pomare, EW, Branch, WJ, et al. (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227.
8Dankert, J, Zijlstra, JB & Wolthers, BG (1981) Volatile fatty acids in human peripheral and portal blood: quantitative determination vacuum distillation and gas chromatography. Clin Chim Acta 110, 301–307.
9Remesy, C & Demigne, C (1976) Partition and absorption of valatile fatty acids in the alimentary canal of the rat. Ann Rech Vet 7, 39–55.
10Storer, GB, Trimble, RP, Illman, RJ, et al. (1983) Effects of dietary oat bran and diabetes on plasma and caecal volatile fatty acids in the rat. Nutr Res 3, 519–526.
11Wolever, TM, Josse, RG, Leiter, LA, et al. (1997) Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805–811.
12Tazoe, H, Otomo, Y, Kaji, I, et al. (2008) Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59, Suppl. 2, 251–262.
13Samuel, BS, Shaito, A, Motoike, T, et al. (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105, 16767–16772.
14Ekblad, E & Sundler, F (2002) Distribution of pancreatic polypeptide and peptide YY. Peptides 23, 251–261.
15Girard, J (2008) The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. Diabetes Metab 34, 550–559.
16Tolhurst, G, Heffron, H, Lam, YS, et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364–371.
17Regard, JB, Kataoka, H, Cano, DA, et al. (2007) Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest 117, 4034–4043.
18Kebede, MA, Alquier, T, Latour, MG, et al. (2009) Lipid receptors and islet function: therapeutic implications? Diabetes Obes Metab 11, Suppl. 4, 10–20.
19Bahar Halpern, K, Veprik, A, Rubins, N, et al. (2012) GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of a bicistronic mRNA encoding GPR40 and GPR41. J Biol Chem 287, 20154–20163.
20Zaibi, MS, Stocker, CJ, O'Dowd, J, et al. (2010) Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett 584, 2381–2386.
21Xiong, Y, Miyamoto, N, Shibata, K, et al. (2004) Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 101, 1045–1050.
22Hong, YH, Nishimura, Y, Hishikawa, D, et al. (2005) Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146, 5092–5099.
23Kimura, I, Inoue, D, Maeda, T, et al. (2011) Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A 108, 8030–8035.
24Wargent, E, Sennitt, MV, Stocker, C, et al. (2005) Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation. Lipids Health Dis 4, 3.
25Stocker, CJ, Wargent, E, O'Dowd, J, et al. (2007) Prevention of diet-induced obesity and impaired glucose tolerance in rats following administration of leptin to their mothers. Am J Physiol Regul Integr Comp Physiol 292, R1810–R1818.
26Weir, JB (1949) New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109, 1–9.
27Wang, S, Subramaniam, A, Cawthorne, MA, et al. (2003) Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle. Diabetes Obes Metab 5, 295–301.
28Ngala, RA, O'Dowd, J, Wang, SJ, et al. (2008) Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and β2-adrenoceptor mechanisms. Br J Pharmacol 155, 395–406.
29Morgan, AD, Carroll, ME, Loth, AK, et al. (2003) Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice. Neuropsychopharmacology 28, 932–938.
30Sleeth, ML, Thompson, EL, Ford, HE, et al. (2010) Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr Res Rev 23, 135–145.
31Butler, AA & Kozak, LP (2010) A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59, 323–329.
32Arch, JR, Hislop, D, Wang, SJ, et al. (2006) Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int J Obes (Lond) 30, 1322–1331.
33Fruebis, J, Tsao, TS, Javorschi, S, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98, 2005–2010.
34Qi, Y, Takahashi, N, Hileman, SM, et al. (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10, 524–529.
35Garaulet, M, Hernandez-Morante, JJ, de Heredia, FP, et al. (2007) Adiponectin, the controversial hormone. Public Health Nutr 10, 1145–1150.
36Warren, JM, Simon, VA, Bartolini, G, et al. (2003) Trans-10, cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes. Lipids 38, 497–504.
37Liu, LF, Purushotham, A, Wendel, AA, et al. (2007) Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Am J Physiol Gastrointest Liver Physiol 292, G1671–G1682.
38Martin, AI, Castillero, E, Granado, M, et al. (2008) Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis. J Endocrinol 197, 111–119.
39Hwang, LL, Wang, CH, Li, TL, et al. (2010) Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity (Silver Spring) 18, 463–469.
40Garcia-Barrado, MJ, Iglesias-Osma, MC, Moreno-Viedma, V, et al. (2011) Differential sensitivity to adrenergic stimulation underlies the sexual dimorphism in the development of diabetes caused by Irs-2 deficiency. Biochem Pharmacol 81, 279–288.
41Garg, N, Thakur, S, McMahan, CA, et al. (2011) High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice. Biochem Biophys Res Commun 413, 476–480.
42Taraschenko, OD, Maisonneuve, IM & Glick, SD (2011) Sex differences in high fat-induced obesity in rats: effects of 18-methoxycoronaridine. Physiol Behav 103, 308–314.
43Uceyler, N, Schutt, M, Palm, F, et al. (2011) Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. Int J Obes (Lond) 34, 701–711.
44Mayes, JS & Watson, GH (2004) Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5, 197–216.
45Brown, LM & Clegg, DJ (2010) Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 122, 65–73.
46Loizzo, S, Vella, S, Loizzo, A, et al. (2010) Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances. Peptides 31, 1598–1605.
47Justo, R, Boada, J, Frontera, M, et al. (2005) Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis. Am J Physiol Cell Physiol 289, C372–C378.
48Oh, TS, Choi, JW, Choi, DK, et al. (2011) Gender dimorphism in skeletal muscle proteome between lean and diet-induced obese rats. Cell Physiol Biochem 28, 981–996.
49Choi, DK, Oh, TS, Choi, JW, et al. (2011) Gender difference in proteome of brown adipose tissues between male and female rats exposed to a high fat diet. Cell Physiol Biochem 28, 933–948.
50Monjo, M, Rodriguez, AM, Palou, A, et al. (2003) Direct effects of testosterone, 17 beta-estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis. Endocrinology 144, 4923–4930.
51Bjursell, M, Admyre, T, Goransson, M, et al. (2011) Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab 300, E211–E220.